ECO Animal Health Group plc (AIM:EAH)

Market Cap	75.89M +73.6%
Revenue (ttm)	85.81M +1.4%
Net Income	3.02M +359.0%
EPS	0.04 +352.1%
Shares Out	67.76M
PE Ratio	25.80
Forward PE	39.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,779
Average Volume	61,415
Open	106.63
Previous Close	108.00
Day's Range	106.00 - 112.00
52-Week Range	50.00 - 116.90
Beta	-0.02
RSI	58.31
Earnings Date	Mar 2, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 200
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In fiscal year 2025, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.